Role of T lymphocytes in the pathogenesis of chlamydia disease

Journal of Infectious Diseases

Volumn 200, Issue 6, 2009, Pages 926-934

  Lgietseme, Joseph U ^a,b,d   He, Qing ^a,b   Joseph, Kahaliah ^a   Eko, Francis O ^b   Lyn, Deborah ^b   Ananaba, Godwin ^c   Campbell, Angela ^c   Bandea, Claudiu ^a   Black, Carolyn M ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b MOREHOUSE SCHOOL OF MEDICINE   (United States)

^c CLARK ATLANTA UNIVERSITY   (United States)

^d NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 10;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HOST; IMMUNITY; IMMUNOPATHOGENESIS; INFERTILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; VACCINATION; ANIMAL; C57BL MOUSE; CELL LINE; FERTILITY; GENETICS; HUMAN; IMMUNOLOGY; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; ANTIGENS, CD4; ANTIGENS, CD8; CELL LINE; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; FERTILITY; HUMANS; INTERLEUKIN-10; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; T-LYMPHOCYTE SUBSETS;

EID: 70349417910     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/605411     Document Type: Article

References (47)

1. Johnson RE, Newhall WJ, Papp JR, et al. Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections-2002. MMWR Recomm Rep 2002;51:1-40.
2. Groseclose SL, Zaidi AA, DeLisle SJ, Levine WC, St Louis ME. Estimated incidence and prevalence of genital Chlamydia trachomatis infections in the United States, 1996. Sex Transm Dis 1999;26:339-344
3. Paavonen J, Wolner-Hanssen P. Chlamydia trachomatis: a major threat to reproduction. J Hum Reprod 1989;4:111-124
4. Westrom L, Joesoef R, Reynolds G, Hadgu A, Thompson SE. Pelvic inflammatory inflammatory disease and infertility: a cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopy results. Sex Transm Dis 1992; 19:185-192
5. Nieuwenhuis RF, Ossewaarde JM, Gotz HM, et al. Resurgence of lymphogranuloma venereum in Western Europe: an outbreak of Chlamydia trachomatis serovar L2 proctitis in The Netherlands among men who have sex with men. Clin Infect Dis 2004; 39:996-1003.
6. Brunham RC, Rekart ML. The arrested immunity hypothesis and the epidemiology of Chlamydia control. Sex Transm Dis 2008; 35:53-54
7. Kilmarx PH, Mock PA, Levine WC. Effect of Chlamydia trachomatis coinfection on HIV shedding in genital tract secretion. Sex Transm Dis 2001;28:347-348
8. Mahdi OS, Byrne GI, Kalayoglu M. Emerging strategies in the diagnosis, prevention and treatment of chlamydial infections. Expert Opin Ther Patents 2001; 11:1253-1265 (Pubitemid 32707659)
9. De la Maza MA, De la Maza LM. A new computer model for estimating the impact of vaccination protocols and its application to the study of Chlamydia trachomatis genital infections. Vaccine 1995; 13:119-127
10. Katz BP, Batteiger BE, Jones RB. Effect of prior sexually transmitted disease on the isolation of Chlamydia trachomatis. Sex Transm Dis 1987;14:160-164
11. Brunham R, Rey-Ladino J. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nat Rev Immunol 2005; 5:149-161
12. Rank RG. Models of immunity. In: Stephens RS, ed. Chlamydia: intracellular biology, pathogenesis and immunity. Washington, DC: ASM Press, 1999:239-295
13. Igietseme JU, Eko FO, Black CM. Contemporary approaches to designing and evaluating vaccines against Chlamydia. Expert Rev Vaccines 2003;2:129-146
14. Morrison RP, Caldwell HD. Immunity to murine chlamydial genital infection. Infect Immun 2002;70:2741-2751 (Pubitemid 34564127)
15. Loomis PW, Stambach MN. T cell responses to Chlamydia trachomatis. Curr Opinion Microbiol 2002;5:87-91.
16. Igietseme JU, Eko FO, He Q, Black CM. Antibody regulation of T-cell immunity: implications for vaccine strategies against intracellular pathogens. Expert Rev Vaccines 2004; 3:23-34. (Pubitemid 38196953)
17. + T cells produce sufficient IFN-gamma to mediate robust protective immunity against genital Chlamydia muridarum infection. J Immunol 2008; 180: 3375-3382
18. Hillis SD, Owens LM, Marchbanks PA, Amsterdam LF, Mac Kenzie WR. Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory disease. Am J Obstet Gynecol 1997; 176:103-107
19. Stephens RS, Lammel CJ. Chlamydia outer membrane protein discovery using genomics. Curr Opin Microbiol 2001;4:16-20.
20. Stephens RS. Chlamydial genomics and vaccine antigen discovery. J Infect Dis 2000; 181:S521-3.
21. Stagg AJ, Tuffrey M, Woods C, Wunderink E, Knight SC. Protection against ascending infection of the genital tract by Chlamydia trachomatis is associated with recruitment of major histocompatibility complex class II antigen-presenting cells into uterine tissue. Infect Immun 1998;66:3535-3544
22. Jenkins MK, DeSilva DR, Johnson JG, Norton SD. Costimulating fac- tors and signals relevant for antigen presenting cell function. Adv Exp Med Biol 1993;329:87-92.
23. Su H, Messer R, Whitmire W, Fischer E, Portis JC, Caldwell HD. Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable chlamydiae. J Exp Med 1998; 188:809-818 (Pubitemid 28433408)
24. Igietseme JU, Ananaba GA, Bolier J, et al. Suppression of endogenous IL-10 gene expression in dendritic cells enhances antigen presentation for enhanced specific Thl induction: potential for cellular vaccine development. J Immunol 2000; 164:4212-4219 (Pubitemid 30215080)
25. Wu HY, Russell MW. Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system. Immunol Res 1997;16:187-201.
26. Kiyono H, Fukuyama S. NALT- versus Peyer's-patch-mediated mucosal immunity. Nat Rev Immunol 2004;4:699-710. (Pubitemid 39223076)
27. Pal S, Theodor I, Peterson EM, de la Maza LM. Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge. Infect Immun 1997;65:3361-3369
28. He Q, Martinez-Sobrido L, Eko FO, et al. Live-attenuated influenza viruses as delivery vectors for Chlamydia vaccines. Immunology 2007; 122:28-37.
29. Igietseme J, He Q, Eko F, et al. Enhanced chlamydial antigen presentation by Fc receptor bearing dendritic cells using Fc-fusion proteins. Proc Annu Meet Am Soc Microbiol, Toronto, Ontario, 2007.
30. Igietseme JU, He Q, Eko Q, et al. Development of vaccines to prevent chlamydial STDs. Mucosal Immunol Update 2005; 13:12-17.
31. Moore T, Ekworomadu C, Eko F, et al. Fc receptor-mediated antibody regulation of T cell immunity against intracellular pathogens. J Infect Dis 2003; 188:617-624 (Pubitemid 37011817)
32. Igietseme J, Q H, Joseph K, et al. Involvement of specific immune response in the pathogenesis of Chlamydia trachomatis disease. In: Christiansen G, ed. Chlamydia research. Vol 6. Aarhus, Denmark: University of Aarhus, 2008:290.
33. Barr EL, Ouburg S, Igietseme JU, et al. Host inflammatory response and development of complications of Chlamydia trachomatis genital infection in CCR5-deficient mice and subfertile women with the CCR5delta32 gene deletion. J Microbiol Immunol Infect 2005; 38: 244-254
34. Pal S, Hui W, Peterson EM, de la Maza LM. Factors influencing the induction of infertility in a mouse model of Chlamydia trachomatis ascending genital infection. J Med Microbiol 1998; 47:599-605.
35. Tuffrey M, Alexander F, Woods C, Taylor-Robinson D. Genetic susceptibility to chlamydial salpingitis and subsequent infertility in mice. J Reprod Fertil 1992;95:31-38
36. Perry LL, Feilzer K, Portis JL, Caldwell HD. Distinct homing pathways direct T lymphocytes to the genital and intestinal mucosae in Chlamydia-infected mice. J Immunol 1998; 160:2905-2914
37. Igietseme JU, Uriri IM, Kumar SN, et al. Route of infection that induces a high intensity of gamma interferon-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice. Infect Immun 1998; 66:4030-4035
38. Ramsey KH, Newhall WJ, Rank RG. Humoral immune response to chlamydial genital infection of mice with the agent of mouse pneumonitis. Infect Immun 1989; 57:2441-2446
39. Kees U, Kynast G, Weber E, Krammer PH. A method for testing the specificity of influenz A virus-reactive memory cytotoxic T lymphocytes (CTL) clones in limiting dilution cultures. J Immunol Methods 1984;69:215-227 (Pubitemid 14135677)
40. Krammer PH, Dy M, Hultner L, et al. Production of lymphokines by murine T cells grown in limiting dilution and long-term cultures. In: Fathman CG, Fitch FW, eds. Isolation, characterization, and utilization of T lymphocyte clones. New York: Academic Press, 1982:252-262
41. Cohen CR, Brunham RC. Pathogenesis of Chlamydia induced pelvic inflammatory disease. Sex Transm Infect 1999;75:21-24
42. Darville T, O'Niell JM, Andrews J, CW, Nagarajan UM, Ojcius DM. Toll-like receptor-2, but not toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection. J Immunol 2003; 171:6187-6197 (Pubitemid 37467242)
43. Cohen CR, Gichui J, Rukaria R, Sinei SS, Gaur LK, Brunham RC. Immunogenetic correlates for Chlamydia trachomatis-associated tubal infertility. Obstet Gynecol 2003; 101:438-444
44. Matsuzaki G, Umemura M. Interleukin-17 as an effector molecule of innate and acquired immunity against infections. Microbiol Immunol 2007;51:1139-1147
45. O'Connell C, Ingalls R, Andrews CJ, Scurlock A, Darville T. Plasmiddeficient Chlamydia muridarum fail to induce immune pathology and protect against oviduct disease. J Immunol 2007; 179:4027-4034
46. Bachmaier K, Neu N, Maza LMdl, Pal S, Hessel A, Penninger JM. Chlamydia infections and heart disease linked through antigenic mimicry. Science 1999;283:1335-1339
47. Li Z, Chen D, Zhong Y, Wang S, Zhong G. The chlamydial plasmidencoded protein pgp3 is secreted into the cytosol of Chlamydia-iniected cells. Infect Immun 2008;76:3415-3428